Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein ∈4 allele

Journal of Clinical Investigation

Volumn 97, Issue 1, 1996, Pages 65-72

  Bergeron, Nathalie ^a   Havel, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apo B100; Apo B48; Apo E polymorphism; Chylomicrons; Very low density lipoproteins

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHYLOMICRON; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; LIPID METABOLISM; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; ALLELES; APOLIPOPROTEIN B-48; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CHOLESTEROL; DIET; DIETARY FATS; EATING; FATTY ACIDS, UNSATURATED; HUMANS; LIPIDS; LIPOPROTEINS; MALE; PHENOTYPE; TRIGLYCERIDES;

EID: 0030045980     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118408     Document Type: Article

References (56)

1. Weisgraber, K H. 1994. Apolipoprotein E: structure-function relationships. In Advances in Protein Chemistry. Vol. 45. Academic Press, Inc., Los Angeles, CA 249-302.
2. Krieger, M., and J. Herz, 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptorrelated protein (LRP) Annu Rev Biochem. 63:601-637.
3. Utermann, G., N. Pruin, and A Steinmetz. 1979. Polymorphism of apohpoprotein E. III Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin. Genet. 15:63-72.
4. Weisgraber, K. H., T L. Innerarity, and R. W. Mahley 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol. Chem. 257 2518-2521.
5. Davignon, J., R. E Gregg, and C F. Sing 1988. Apolipoprotem E polymorphism and atherosclerosis. Arteriosclerosis. 8:1-21.
6. Weintraub, M. S , S Eisenberg, and J. L. Breslow. 1987. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest 80:1571-1577.
7. Brown, A. J., and D. C K. Roberts. 1991. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler. Thromb 11:1737-1744.
8. Boerwinkle, E., S. Brown, A. R. Sharrett, G. Heiss, and W. Patsch. 1994. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am. J. Hum. Genet. 54.341-360
9. Gregg, R. E., L. A. Zech, E. J. Schaefer, D Stark, D. Wilson, and B. Brewer. 1986 Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821.
10. Dallongeville, J., S. Lussier-Cacan, and J. Davignon. 1992. Modulation of plasma triglyceride levels by apoE phenotype. a meta-analysis. J. Lipid Res. 33:447-454.
11. Tiret, L., P. de Knijff, H.-J. Menzel, C. Ehnholm, V. Nicaud, and L. M. Havekes. 1994. Apo E polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. Arterioscler. Thromb. 14:1617-1624.
12. Wilson, P. W F , R. H Myers, M. G. Larson, J. M. Ordovas, P. A. Wolf, and E. J. Schaefer. 1994. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease JAMA (J. Am. Med. Assoc ) 272:1666-1671
13. Stengard, J. H., K. E. Zerba, J. Pekkanen, C. Ehnholm, A Nissinen, and C F. Sing. 1995. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 91: 265-269.
14. Lipid Research Clinics Population Studies Data Book Vol. 1. 1980. National Institutes of Health. DHHS Publication No. 80-1527, Washington D.C. 136 pp.
15. Najjar, M. F., and M. Rowland. Anthropometric Reference Data and Prevalence of Overweight United States, 1976-1980. U.S. Department of Human Services. National Center for Health and Statistics. 1987. DHHS Publication No. 87-1688. Hyattsville, MD. 55 pp.
16. Harris, J. A., and F. G. Benedict. 1919. A Biometric Study of Basal Metabolism in Man. publication no. 279 Carnegie Institution. Washington D.C.
17. Cardin, A. D., K. R. Witt, J. Chao, H. S. Margolius, V. H. Donaldson, and R L. Jackson. 1984. Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J. Biol. Chem 259 8522-8528
18. Havel, R J., H Eder, and J. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin Invest. 34 1345-1353.
19. Allain, C. C., L. S. Poon, C. S. G. Chan, W. Richmond, and P. C Fu. 1974. Enzymatic determination of total serum cholesterol. Clin. Chem 20 470-475
20. Bucolo, G., and H. David. 1973. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:476-482.
21. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28:1379-1388.
22. Kotite, L., N. Bergeron, and R. J. Havel. 1995. Quantification of apohpoproteins B100, B48 and E in human triglycende-rich lipoproteins. J. Lipid Res 36,890-900.
23. Havel, R. J , L. Kotite, J.-L. Vigne, J. P. Kane, P. Tun, N. Phillips, and G C. Chen. 1980. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E J Clin. Invest. 66.1351-1362
24. Pagnan, A., R. J. Havel, J. P. Kane, and L Kotite. 1977. Characterization of human very low density lipoproteins containing two electrophoretic populations, double prebeta lipoproteinemia and primary dysbetalipoproteinemia J Lipid Res. 18 613-622.
25. Superko, H. R., and W. H. Haskell. 1991 The effect of apolipoprotein E isoform difference on postpiandial lipoprotein composition in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol. Stroke. 18:315-325.
26. Schneeman, B O., L. Kotite, K. Todd, and R. J. Havel 1993. Relationship between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans Proc. Natl. Acad. Sci USA. 90:2069-2073.
27. Utermann, G. 1987. Apolipoprotein E polymorphism in health and disease Am. Heart J. 113:433-440.
28. Hallman, D. M., E Boerwinkle, N. Saha, C. Sandholzer, H. J. Menzel, A. Csázár, and G. Utermann. 1991 The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:338-349.
29. Eto. M , K. Watanabe, Y. Iwashima, A. Morikawa, E. Oshima, M. Sekiguchi, and K. Ishu. 1986. Apolipoprotein E polymorphism and hyperlipemia in type II diabeties. Diabetes 35:1374-1382
30. Kobori, S., N. Nakamura, H. Uzawa, and M. Shichiri. 1988. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan Atherosclerosis 69:81-88.
31. Imari, Y , S. Koga, and H. Ibayashi. 1988. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metab. Clin Exp. 37.1134-1138.
32. Gueguen, R., S. Visvikis, J. Steinmetz, G. Siest, and E. Boerwinkle. 1989. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am. J Hum Genet. 45:793-802.
33. Chait, A , A. Onitiri, A. Nicoll, E Rabaya, J. Davies, and B Lewis. 1974. Reduction of serum triglyceride levels by polyunsaturated fat. Studies on the mode of action and on very low density lipoprotein composition. Atherosclerosis. 20:347-364
34. Mattson, F. H., and S. M Grundy 1985. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J. Lipid Res. 26:194-202.
35. Lopez-Miranda, J , J. M. Ordovas, P Mata, A. H. Lichtenstein, B Clevidence, J. T. Judd, and E. J. Schaefer. 1994. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J. Lipid Res. 35:1965-1975.
36. Havel, R. J. 1994. Postprandial hyperlipidemia and remnant lipoproteins. Curr. Opin. Lipidol. 5:102-109.
37. Cohn, J. S., J. R. McNamara, S D. Cohn, J. M Ordovas, and E. J. Schaefer. 1988. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J. Lipid Res 29:925-936.
38. Cohn, J. S , J. R McNamara, S D. Cohn, S. D. Ordovas, and E. J. Sehaefer. 1988 Postprandial plasma lipoprotein changes in human subjects of different ages. J. Lipid Res. 29:469-479.
39. Kashyap, M. L., R. L. Barnhart, L. S. Srivastava, G. Perisutti, C. Allen, E. Hogg, C. J. Glueck, and R. L Jackson 1983. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects. Am J. Clin Nutr 37:233-243.
40. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J. Clin. Invest 79.1110-1119.
41. Krasinski, S D., J. S. Cohn, R. M. Russell, and E. J. Schaefer. 1990. Postprandial plasma vitamin A in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants, Metab. Clin. Exp 39:357-365
42. Cohn, J. S , E. J. Johnson, J. S. Millar, S. D Cohn, R. W. Milne, Y. L. Marcel, R M. Russell, and E. J. Schaefer. 1993. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in plasma concentration of TRL triglycerides and retinyl esters. J. Lipid Res. 34: 2033-2040
43. Havel, R. J. 1994. Triglyceride-rich lipoproteins and atherosclerosis - new perspectives. Am. J Clin. Nutr. 59:795-799
44. Cohen, J. C , T. D. Noakes, and A. J. Spinnler Benade 1989 Postprandial Hpemia and chylomicron clearance in athletes and in sedentary men Am. J. Clin. Nutr. 49:443-447.
45. Pagnan, A., G. Zanetti, A. Bonanome, S Biffanti, C Ehnholm, L. Keso, and M. Lukka 1987. Apolipoprotein E polymorphism, serum hpids and occurrence of double 'pre-betalipoproteinemia' (DPBL) in subjects from two different populations. Atherosclerosis. 65:23-28.
46. Steinmeitz, A., C. Jakobs, S. Motzny, and H. Kaffarnik. 1989. Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis. 9.405-411
47. Weisgraber, K. H. 1990. Apolipoprotein E among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res. 31:1503-1511.
48. Weisgraber, K. H., and R. W. Mahley. 1978. Apoprotein (E-AII) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J. Biol. Chem. 253:6281-6288.
49. 125I-apolipoprotein E. J. Biol. Chem. 256:3963-3968.
50. Gianturco, S. H., F. B. Brown, A. M. Gotto, and W. A. Bradley. 1982. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal skin fibroblasts. J. Lipid Res. 23:984-993.
51. Bradley, W. A., S.-L. C. Hwang, J. B Karlin, H. Y. Lin, S. C. Prasad, A. M. Gotto, and S. H. Gianturco. 1984. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very low density lipoprotein to low density lipoproteins. J. Biol. Chem. 259:14728-14735.
52. Bradley, W. A., and S. H. Gianturco. 1986. Apo E is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apo B is unnecessary. J. Lipid Res. 27:40-48.
53. Dergunov, A. D., and M. Rosseneu. 1994. The significance of apolipoprotein E structure to the metabolism of plasma triglycende-rich lipoproteins. Biol. Chem. Hoppe.-Seyler. 375:485-495.
54. Fielding, P. E., Y. Ishikawa, and C. J. Fielding. 1989. Apolipoprotein E mediates binding of normal very low density lipoprotein to heparin but is not required for high affinity receptor binding. J. Biol. Chem. 264:12462-12466.
55. Campos, E., K. Nakajima, A. Tanaka, and R. J. Havel. 1992. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J. Lipid Res. 33:369-380.
56. Havel, R. J., N. Yamada, and D. M. Shames. 1989. Watanabe heritable hyperlipidemic rabbit. Arteriosclerosis. 9:(Suppl. 1):I33-I38.